Opening up the Ivory Tower.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17540161.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Big pharma is increasingly looking to academia for new drug leads and technologies; meanwhile universities are being forced to look beyond the National Institutes of Health (NIH) for funding. This mutual attraction-out-of-necessity is helping to forge new bonds between industry and academia.
Medical subject headings
- Drug Industry
- Universities